Literature DB >> 15079851

Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.

Brian E Leonard1, Denise McCartan, John White, David J King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15079851     DOI： 10.1002/hup.579

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN： 0885-6222            Impact factor:   1.672


× No keyword cloud information.
  46 in total

1.  Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.

Authors:  Stefanie Mache; Patrick Eickenhorst; Karin Vitzthum; Burghard F Klapp; David A Groneberg
Journal:  Wien Med Wochenschr       Date:  2012-06-16

Review 2.  Psychostimulant treatment of cocaine dependence.

Authors:  John J Mariani; Frances R Levin
Journal:  Psychiatr Clin North Am       Date:  2012-04-26

3.  The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task.

Authors:  Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

Review 4.  Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors:  Susan E Hardy
Journal:  Am J Geriatr Pharmacother       Date:  2009-02

5.  Inferring candidate genes for attention deficit hyperactivity disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS).

Authors:  M Reuter; P Kirsch; J Hennig
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

Review 6.  Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility?

Authors:  Rosella Ciurleo; Placido Bramanti; Rocco Salvatore Calabrò
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 7.  Interventions for attention problems after pediatric traumatic brain injury: what is the evidence?

Authors:  Barynia Backeljauw; Brad G Kurowski
Journal:  PM R       Date:  2014-04-19       Impact factor: 2.298

Review 8.  [Functional imaging of neurocognitive dysfunction in attention deficit hyperactivity disorder].

Authors:  I Wolf; H Tost; M Ruf; M H Schmidt; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

9.  Treatment of disorders of hypersomnolence.

Authors:  Olufemi Adenuga; Hrayr Attarian
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

10.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.